With a faltering economy, increased competition generated by generic drugs, skyrocketing costs of marketing blockbusters, and unsustainable R&D expenditures, pharmaceutical companies are looking for ways to reduce costs and improve the effectiveness of their drug discovery and development operations.
In a move to boost the bilateral trade relationship between Malaysia and India, Malaysian Biotechnology Corporation (BiotechCorp), the lead development agency for the biotechnology industry in Malaysia, kicked off their first business development engagement for 2009 in Hyderabad and Chennai with the Indian media members and industry participants. The latest updates on the Indian-Malaysian investment initiatives were shared to address the current challenging economic climate.
Hyderabad based MedPlus Healthcare Services, the chain of full service pharmacies, is gearing up to stretch out its clinical arm, the Integrated Health Centres, across the country. This is further to its expansion plan of pharmacy chain with 10,000 outlets in next five years.